Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Biotech Market
Biotech News
Biotech Stocks

Home
Life Science Investing News

Amgen to Acquire Rodeo Therapeutics Corporation

Investing News Network

March 30, 2021

The Conversation (0)

Latest News

Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial

March Quarterly Appendix 4C

March Quarterly Activities Report

Appendix 4C and Quarterly Activities Report - March 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Latest Press Releases

Finlay Minerals Receives TSX Venture Exchange Approval for PIL Earn-In Agreement

02 May

Empire Metals Limited Announces Conference Presentations in Australia & N America

02 May

Metals & Mining Virtual Investor Conference Agenda Announced for May 6-8th

02 May

Metals & Mining Virtual Investor Conference Agenda Announced for May 6-8th

02 May

Related News

Editor's Picks: Gold Pulls Back, Experts Not Worried; Eyes on Fed Next Week

02 May

John Rubino: Gold on "Epic Run" as Chaos Unfolds, What About Silver?

02 May

Top 5 Canadian Mining Stocks This Week: Lion Rock Jumps 60 Percent

02 May

Copper Investing

Finlay Minerals Receives TSX Venture Exchange Approval for PIL Earn-In Agreement

02 May

Critical Metals Investing

Deep-Sea Crisis: Can the ISA Regain Control of the Deep Ocean?

02 May

Critical Metals Investing

Opportunity or Overreach: Is Australia Making the Right Moves for Critical Minerals?

02 May

Critical Metals Investing

Ontario Tables Sweeping Bill to Restrict Foreign Access to Critical Minerals

02 May

TOP STOCKS

American Battery4.030.24

Aion Therapeutic0.10-0.01

Cybin Corp2.140.00

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.